Tetra Bio-Pharma Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Public

  • Employees
  • 33

Employees

  • Stock Symbol
  • TBPMQ

Stock Symbol

  • Investments
  • 7

Tetra Bio-Pharma General Information

Description

Tetra Bio Pharma Inc is a biopharmaceutical leader in cannabinoid-based drug. It discovers and develops clinical programs aimed at bringing novel prescription drugs and treatments to patients and their healthcare providers. The company with its subsidiaries engaged in the development of an advanced and growing pipeline of Bio Pharmaceuticals and Veterinary Products containing cannabinoids. Tetra Bio-Pharma is focused on providing rigorous scientific validation and safety data required for inclusion into the existing bio pharma industry by regulators, physicians and insurance companies.

Contact Information

Formerly Known As
GrowPros Cannabis Ventures
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Stock Exchange
PINX
Corporate Office
  • 2316 Saint Joseph Boulevard
  • Orleans, Ontario K1C 1E8
  • Canada
+1 (343) 000-0000

Tetra Bio-Pharma Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Tetra Bio-Pharma Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$84.7K 284K -$0.06

Tetra Bio-Pharma Financials Summary

In Thousands,
USD
TTM 31-Aug-2022 FY 2021 30-Nov-2021 FY 2020 30-Nov-2020 FY 2019 30-Nov-2019
EV 19,727 64,932 31,703 55,124
Revenue 0 0 0 0
EBITDA (30,213) (40,078) (15,775) (9,885)
Net Income (30,653) (41,594) (19,686) (11,494)
Total Assets 2,306 5,926 22,595 21,497
Total Debt 1,268 2,442 1,540 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Tetra Bio-Pharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Tetra Bio-Pharma‘s full profile, request access.

Request a free trial

Tetra Bio-Pharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Tetra Bio Pharma Inc is a biopharmaceutical leader in cannabinoid-based drug. It discovers and develops clinical program
Drug Discovery
Orleans, Canada
33 As of 2022
000.00
000000000 000.00

000000

ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercita
0000 000000000
Oxford, United Kingdom
00 As of 0000
0000
000.00 0000-00-00
00000000 0000

00000

tur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna
00000 00000000000000
Vancouver, Canada
00.000
000000000 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Tetra Bio-Pharma Competitors (8)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Oxford Cannabinoid Technologies Formerly VC-backed Oxford, United Kingdom 00 0000 00000000 0000
Lotus Cannabis Company Corporation Vancouver, Canada 00.000 000000000 00.000
FSD-Pharma Corporation Toronto, Canada 00 000.00 00000000 000.00
Repare Therapeutics Formerly VC-backed Montreal, Canada 000 00000 00000000 00000
Revive Therapeutics Corporation Toronto, Canada 0 000.00 000000000 000.00
You’re viewing 5 of 8 competitors. Get the full list »

Tetra Bio-Pharma Executive Team (22)

Name Title Board Seat Contact Info
Guy Chamberland Ph.D Chief Executive Officer & Board Member
Leslie Auld Chief Financial Officer, Finance
Natalie Leroux Director, Investor Relations
Randy Ringuette Ph.D Director, Manufacturing Sciences & Technology
Charles Campbell Director, Research & Development
You’re viewing 5 of 22 executive team members. Get the full list »

Tetra Bio-Pharma Board Members (10)

Name Representing Role Since
00000 000000 00 Self Chairman & Board Member 000 0000
000000000 0000 Tetra Bio-Pharma Board Member 000 0000
0000 0000 Tetra Bio-Pharma Board Member 000 0000
000 00000000000 00 Tetra Bio-Pharma Chief Executive Officer & Board Member 000 0000
0000 000 Self Board Member 000 0000
You’re viewing 5 of 10 board members. Get the full list »

Tetra Bio-Pharma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Tetra Bio-Pharma Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Tetra Bio-Pharma‘s full profile, request access.

Request a free trial

Tetra Bio-Pharma Investments & Acquisitions (7)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
TALLC (Drug Discovery) 03-Jun-2020 000000000 Drug Discovery 000000 0é
CB2 Therapeutics 21-Aug-2019 00000 0000 Pharmaceuticals 000 00000
Panag Pharma 01-May-2019 0000000000 000.00 Drug Discovery 000 00000
Joint Venture (Tetra Bio-Pharma and Altus Formulation) 29-Apr-2019 00000 0000 Drug Delivery 000 00000
Phytopain Pharma 19-Mar-2018 Secondary Transaction - Private 000.00 Pharmaceuticals 0000000 0
You’re viewing 5 of 7 investments and acquisitions. Get the full list »

Tetra Bio-Pharma Subsidiaries (1)

Company Name Industry Location Founded
Panag Pharma Drug Discovery Halifax, Canada 0000
To view Tetra Bio-Pharma’s complete subsidiaries history, request access »

Tetra Bio-Pharma Exits (2)

Company Name Exit Date Exit Type Exit Size Status Buyers
Holizen 22-Jun-2016 000000000000000000 00000 Completed
  • 00000 000-000000
Export Hydro 06-Nov-2015 Merger/Acquisition 000 Completed
To view Tetra Bio-Pharma’s complete exits history, request access »

Tetra Bio-Pharma FAQs

  • When was Tetra Bio-Pharma founded?

    Tetra Bio-Pharma was founded in 2007.

  • Who is the founder of Tetra Bio-Pharma?

    Ryan Brown and Andre Rancourt are the founders of Tetra Bio-Pharma.

  • Who is the CEO of Tetra Bio-Pharma?

    Guy Chamberland Ph.D is the CEO of Tetra Bio-Pharma.

  • Where is Tetra Bio-Pharma headquartered?

    Tetra Bio-Pharma is headquartered in Orleans, Canada.

  • What is the size of Tetra Bio-Pharma?

    Tetra Bio-Pharma has 33 total employees.

  • What industry is Tetra Bio-Pharma in?

    Tetra Bio-Pharma’s primary industry is Drug Discovery.

  • Is Tetra Bio-Pharma a private or public company?

    Tetra Bio-Pharma is a Public company.

  • What is Tetra Bio-Pharma’s stock symbol?

    The ticker symbol for Tetra Bio-Pharma is TBPMQ.

  • What is the current market cap of Tetra Bio-Pharma?

    The current market capitalization of Tetra Bio-Pharma is $84.7K.

  • Who are Tetra Bio-Pharma’s competitors?

    Oxford Cannabinoid Technologies, Lotus Cannabis Company, FSD-Pharma, Repare Therapeutics, and Revive Therapeutics are some of the 8 competitors of Tetra Bio-Pharma.

  • What is Tetra Bio-Pharma’s annual earnings per share (EPS)?

    Tetra Bio-Pharma’s EPS for 12 months was -$0.06.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »